Clinical trial · Observational
Study of Association Between Peripheral Immune Cells and Recurrence in Stage II/III Colorectal Cancer
NCT01911988CI-TRIAL-00024371PICC-1unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine association between Peripheral Immune Cells(PIC) and recurrence in stage II/III colorectal cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Colon&Rectal Stage II /Stage III
Primary outcomes (1)
- measure
- Disease Free Survival
- timeFrame
- 5 years
- description
- The time from resection to the time of disease recurrence(local or metastatic) or death from any cause.
Secondary outcomes (1)
- measure
- 5 years overall survival
- timeFrame
- 5 years or the time of death
- description
- the time from resection to the time of death from any cause
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Clinically /Pahohistologically diagnosed as stageII/III CRC * ECOG 0-2 * Age 18-90 * Gender both Exclusion Criteria: * Distant metastases noticed before or during surgery * History of malignant tumor disease * History of autoimmune diseases or immunodeficiencies * History of hematological disease * History of hepatic cirrhosis or Splenomegaly * History of chronic kidney disease * History of organ transplant * History of chronic inflammatory disease * Use of hematological drugs within 1 year prior to surgery * Use of immunodulatory drugs within 1 year prior to surgery * Use of chemotherapeutic drugs within 1 year prior to surgery * Long term Use of non-steroid anti-inflammatory drugs(\>6 months) * Unable or Unwilling to undergo all the standard treatment
References
Publications (0)
Data not yet available
No reference posted for this study.